{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:48:45Z","timestamp":1792730925069,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.amjmed.2003.07.011","type":"journal-article","created":{"date-parts":[[2003,12,18]],"date-time":"2003-12-18T05:35:35Z","timestamp":1071725735000},"page":"721-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"title":["Hypercoagulability in sickle cell disease: a curious paradox"],"prefix":"10.1016","volume":"115","author":[{"given":"Kenneth I","family":"Ataga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene P","family":"Orringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2003.07.011_BIB1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.STR.9.1.45","article-title":"Cerebrovascular disease in sickle cell anemia","volume":"9","author":"Meckel","year":"1978","journal-title":"Stroke"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-2007-1006393","article-title":"Sickle cell disease and the pulmonary circulation","volume":"15","author":"Kirkpatrick","year":"1994","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB3","first-page":"169","article-title":"Enhanced thrombin generation in children with sickle cell disease","volume":"71","author":"Peters","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.V68.1.317.317","article-title":"Fragment D-dimer levels","volume":"68","author":"Devine","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00001721-199504000-00001","article-title":"Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls","volume":"6","author":"Hagger","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB6","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/blood.V91.11.4216","article-title":"Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease","volume":"91","author":"Key","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2141.1992.tb02989.x","article-title":"Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients","volume":"81","author":"Kurantsin-Mills","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2141.1994.tb08316.x","article-title":"Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation","volume":"87","author":"Kurantsin-Mills","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00282-996-0279-2","article-title":"Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease","volume":"38","author":"Nsiri","year":"1996","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R","article-title":"Disturbance of plasma and platelet thrombospondin levels in sickle cell disease","volume":"51","author":"Browne","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB11","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1172\/JCI1932","article-title":"Tissue factor expression by endothelial cells in sickle cell anemia","volume":"101","author":"Solovey","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB12","first-page":"137","article-title":"Platelet function in sickle cell disease during steady state","volume":"32","author":"Triadou","year":"1990","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00001721-199104000-00018","article-title":"Platelets, coagulation, and fibrinolysis in sickle cell disease","volume":"2","author":"Francis","year":"1991","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.V99.1.36","article-title":"The hypercoagulable state in thalassemia","volume":"99","author":"Eldor","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB15","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJM199711273372210","article-title":"Sickle cell disease and the endothelium [editorial]","volume":"337","author":"Lubin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-4157(91)90019-S","article-title":"Transbilayer movement of phospholipids in red cell and platelet membranes","volume":"1071","author":"Schroit","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB17","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1073\/pnas.81.12.3751","article-title":"ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane","volume":"81","author":"Seigneuret","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0009-3084(94)90177-5","article-title":"Maintenance and consequences of membrane phospholipid asymmetry","volume":"73","author":"Devaux","year":"1994","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB19","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1073\/pnas.85.18.6783","article-title":"Measurement of outward translocation of phospholipids across human erythrocyte membrane","volume":"85","author":"Bitbol","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB20","doi-asserted-by":"crossref","first-page":"19412","DOI":"10.1016\/S0021-9258(18)41791-7","article-title":"Bidirectional transbilayer movement of phospholipid analogs in human red blood cells","volume":"267","author":"Connor","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002329900051","article-title":"Role of translocases in the generation of phosphatidyl-serine asymmetry","volume":"151","author":"Diaz","year":"1996","journal-title":"J Membr Biol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V87.3.1179.bloodjournal8731179","article-title":"Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V","volume":"87","author":"Kuypers","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.1979.tb05851.x","article-title":"Erythrocyte membrane lipid reorganization during the sickling process","volume":"41","author":"Chiu","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB24","doi-asserted-by":"crossref","first-page":"8435","DOI":"10.1016\/S0021-9258(20)82083-3","article-title":"Accelerated transbilayer movement of phosphatidylcholine in sickled erythrocytes. A reversible process","volume":"258","author":"Franck","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB25","first-page":"741","article-title":"Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding","volume":"123","author":"Tait","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0038-1650577","article-title":"Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and \u03b2-thalassemia","volume":"76","author":"Helley","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.V96.3.1119","article-title":"Fetal hemoglobin in sickle cell disease","volume":"96","author":"Setty","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1172\/JCI111672","article-title":"Uncoupling of the membrane skeleton from the lipid bilayer","volume":"75","author":"Franck","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood.V58.2.398.398","article-title":"Sickled erythrocytes accelerate clotting in vitro","volume":"58","author":"Chiu","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB30","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198005013021803","article-title":"Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity","volume":"302","author":"Hebbel","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB31","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/blood.V98.12.3228","article-title":"Thrombophilia in sickle cell disease","volume":"98","author":"Setty","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ajh.2830420409","article-title":"Antiphospholipid antibodies in sickle cell disease","volume":"42","author":"Kucuk","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/ard.51.5.671","article-title":"Antiphospholipid antibodies in homozygous sickle cell disease","volume":"51","author":"De Ceular","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB34","first-page":"107","article-title":"Antiphospholipid antibodies","volume":"40","author":"Nsiri","year":"1998","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB35","doi-asserted-by":"crossref","unstructured":"Ginsberg JS, Demers C, Brill-Edwards, et al. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med. 1995;98:379\u2013383","DOI":"10.1016\/S0002-9343(99)80317-9"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB36","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1073\/pnas.93.16.8606","article-title":"A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice","volume":"93","author":"Olee","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-2143(99)90149-X","article-title":"Antiphospholipid antibodies, protein C and S, and coagulation changes in sickle cell disease","volume":"134","author":"Westerman","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/096120339400300406","article-title":"Physiology of membrane lipid asymmetry","volume":"3","author":"Bevers","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB39","first-page":"168","article-title":"Induction of endothelial cell tissue factor activity in sera from patients with antiphospholipid syndrome. a possible mechanism of thrombosis","volume":"10","author":"Branch","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/096120339600500307","article-title":"Antiphospholipid antibodies (APL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus","volume":"5","author":"Martini","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB41","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/blood.V91.11.4216","article-title":"Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease","volume":"91","author":"Key","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15513810109168816","article-title":"Hemostatic alterations in sickle cell disease","volume":"20","author":"Stuart","year":"2001","journal-title":"Pediatr Pathol Mol Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","volume":"137","author":"Tomer","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB44","first-page":"105","article-title":"Elevated fibrin D-dimer fragment in sickle cell anemia","volume":"19","author":"Francis","year":"1989","journal-title":"Haemostasis"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ajh.2830230403","article-title":"Is sickle cell crisis a thrombotic event?","volume":"23","author":"Green","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2141.1975.tb00530.x","article-title":"Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica","volume":"30","author":"Leslie","year":"1975","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000204519","article-title":"Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis","volume":"89","author":"Papadimitriou","year":"1993","journal-title":"Acta Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2141.2000.02353.x","article-title":"Platelet and leucocyte activation in childhood sickle cell disease","volume":"111","author":"Inwald","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB49","first-page":"604","article-title":"Increased RBC phosphatidylserine exposure in sickle cell disease patients at risk for stroke by transcranial Doppler screening","volume":"90","author":"Styles","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB50","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2141.1998.01121.x","article-title":"Prothrombotic changes in children with sickle cell disease","volume":"103","author":"Liesner","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB51","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2141.1997.2663083.x","article-title":"Protein C and S in homozygous sickle cell disease","volume":"98","author":"Wright","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB52","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajh.2830470409","article-title":"Erythrocyte membrane vesicles and irreversibly sickled cells bind protein S","volume":"47","author":"Lane","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/088307389701200103","article-title":"Protein C and S activity in sickle cell disease and stroke","volume":"12","author":"Tam","year":"1997","journal-title":"J Child Neurol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB54","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1055\/s-0037-1615083","article-title":"Reduced protein C levels\u2014a contributory factor for stroke in sickle cell disease","volume":"79","author":"Khanduri","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.1979.tb03685.x","article-title":"Serial changes in coagulation and viscosity during sickle-cell crisis","volume":"41","author":"Richardson","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2141.1993.tb04671.x","article-title":"Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II","volume":"83","author":"Porter","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB57","first-page":"242","article-title":"Plasma antithrombin III levels in children with homozygous sickle cell disease (SCD)","volume":"18","author":"Karayalcin","year":"1984","journal-title":"Pediatr Res"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB58","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-111-6-534","article-title":"Antithrombin III concentrate for the treatment of chronic leg ulcers in sickle cell-\u03b2 thalassemia","volume":"111","author":"Cacciola","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB59","first-page":"44","article-title":"Platelet function and survival in sickle cell disease","volume":"82","author":"Haut","year":"1973","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-0038-1661088","article-title":"A double-blind trial of ticlopidine in sickle cell disease","volume":"51","author":"Semple","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB61","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jcp.33.7.622","article-title":"Platelet hyperactivity in sickle cell disease","volume":"33","author":"Kenny","year":"1980","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB62","first-page":"17","article-title":"Platelet activation during steady state sickle cell disease","volume":"14","author":"Westwick","year":"1983","journal-title":"J Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB63","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3476(80)80804-3","article-title":"Abnormalities of platelet aggregation in sickle cell disease","volume":"96","author":"Mehta","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0049-3848(77)90145-1","article-title":"Platelet function in sickle cell anemia","volume":"10","author":"Gruppo","year":"1977","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB65","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-3476(74)80504-4","article-title":"Abnormalities of platelet aggregation in the vasooclusive crises of sickle cell anaemia","volume":"85","author":"Stuart","year":"1974","journal-title":"J Pediatr"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2143(97)90005-6","article-title":"Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia","volume":"129","author":"Wun","year":"1997","journal-title":"J Clin Lab Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB67","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.ATV.20.10.2322","article-title":"Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression","volume":"20","author":"Lindmark","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB68","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000204390","article-title":"Blood proteins C and S in sickle cell disease","volume":"90","author":"El-Hazmi","year":"1993","journal-title":"Acta Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB69","first-page":"571","article-title":"Protein S deficiency in sickle cell anemia","volume":"111","author":"Francis","year":"1988","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB70","first-page":"320","article-title":"Plasma protein C levels in children with sickle cell disease","volume":"11","author":"Karayalcin","year":"1989","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB71","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V46.4.579.579","article-title":"Elevated platelet count and megathrombocyte number in sickle cell anemia","volume":"46","author":"Freedman","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB72","first-page":"440","article-title":"Haemostatic alterations accompanying sickle cell pain crisis","volume":"88","author":"Alkjaersig","year":"1976","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB73","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/jcp.40.12.1487","article-title":"Coagulation changes in homozygous sickle cell disease in Nigeria [letter]","volume":"40","author":"Famodu","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB74","first-page":"210","article-title":"Sickle discocytes form more rouleaux in vitro than normal erythrocytes","volume":"93","author":"Obiefuna","year":"1990","journal-title":"J Trop Med Hyg"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<46::AID-AJH9>3.0.CO;2-#","article-title":"Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil","volume":"59","author":"Andrade","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB76","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-8652(199701)54:1<12::AID-AJH2>3.0.CO;2-7","article-title":"Factor V Leiden is not responsible for stroke in patients with sickling disorders and is uncommon in African Americans with sickle cell disease","volume":"54","author":"Kahn","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB77","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2141.1999.01728.x","article-title":"The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and stroke","volume":"107","author":"Cumming","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB78","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2141.1999.01361.x","article-title":"Born to clot","volume":"105","author":"Rees","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB79","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1365-2141.1997.d01-2084.x","article-title":"Activated protein C resistance in homozygous sickle cell disease","volume":"96","author":"Wright","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB80","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00043426-199909000-00011","article-title":"Correlation of the C677T MTHFR genotype with homocysteine levels in children with sickle cell disease","volume":"21","author":"Balasa","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB81","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9343(97)00129-0","article-title":"Homocysteine in sickle cell disease","volume":"103","author":"Houston","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB82","first-page":"695","article-title":"MTHFR (5,10-methylenetetrahydrofolate reductase) 677 C\u2192T mutation as a candidate risk factor for avascular necrosis (AVN) in patients with sickle cell disease","volume":"82","author":"Kutlar","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB83","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ajh.1055","article-title":"Frequency of the 677 C\u2192T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients","volume":"66","author":"Adekile","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB84","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<267::AID-AJH1>3.0.CO;2-W","article-title":"Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease","volume":"59","author":"Zimmerman","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB85","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM196307252690403","article-title":"Long-term anticoagulation in sickle cell disease","volume":"269","author":"Salvaggio","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB86","first-page":"574","article-title":"Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises","volume":"66","author":"Chaplin","year":"1989","journal-title":"East Afr Med J"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB87","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2141.1995.tb05607.x","article-title":"Low-intensity oral anticoagulation in sickle-cell disease reverses the prothrombotic state","volume":"90","author":"Wolters","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB88","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.1175","article-title":"Low adjusted dose acenocoumarol therapy in sickle cell disease","volume":"68","author":"Schnog","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB89","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0038-1650055","article-title":"Aspirin-dipyridamole prophylaxis of sickle cell pain crises","volume":"43","author":"Chaplin","year":"1980","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB90","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000207105","article-title":"Therapeutic effect of aspirin in sickle cell anaemia","volume":"66","author":"Osamo","year":"1981","journal-title":"Acta Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB91","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3476(83)80258-3","article-title":"Trial of low doses of aspirin as prophylaxis in sickle cell disease","volume":"102","author":"Greenberg","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB92","first-page":"213","article-title":"Clinical and biological double-blind study of ticlopidine in preventive treatment of sickle-cell disease crises","volume":"15","author":"Cabannes","year":"1984","journal-title":"Agents Actions Suppl"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000206360","article-title":"Treatment of sickle cell diseases with aspirin","volume":"72","author":"Zago","year":"1984","journal-title":"Acta Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB94","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Multicenter study of hydroxyurea in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB95","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2141.2000.02040.x","article-title":"Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin","volume":"109","author":"Hillery","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB96","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V95.2.368","article-title":"Monoclonal antibodies to \u03b1V\u03b23 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor","volume":"95","author":"Kaul","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB97","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.V99.1.30","article-title":"Elastic tissue abnormalities resembling pseudoxanthoma elasticum in \u03b2 thalassemia and the sickling syndromes","volume":"99","author":"Aessopolos","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2003.07.011_BIB98","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/s-0037-1615948","article-title":"Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids","volume":"85","author":"Tomer","year":"2001","journal-title":"Thromb Haemost"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934303005588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934303005588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:26:51Z","timestamp":1757579211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934303005588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":98,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0002934303005588"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2003.07.011","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypercoagulability in sickle cell disease: a curious paradox","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2003.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}